Electrophysiology

The FARAPULSE PFA System was purposefully built from the ground up to deliver PFA therapy and is optimized for patient safety and procedural ease, addressing many risks associated with traditional thermal cardiac ablation. The FARAPULSE system uses a novel, non-thermal, tissue-selective method for cardiac ablation that is fundamentally different from traditional modalities, which enables physicians to efficiently ablate cardiac tissue while minimizing procedural complications, such as impact to surrounding structures.^5,6

The proprietary puncture technology of the VersaCross RF Transseptal Solution enables safe and reliable left heart access to deliver critical cardiac therapies. By using RF energy instead of conventional mechanical needles, left heart access has become more predictable, with reduced rates of serious complications. The platform reimagines left heart access by reducing device exchanges during a procedure, while still using standard-of-care RF puncture technology.

The POLARx Cryoablation System is designed to provide greater physician control and increased procedural predictability during cardiac ablations. Combining a modernized console, balloon catheter, steerable sheath and circular mapping catheter, the POLARx System creates a direct path to pulmonary vein isolation while providing safe, efficient and effective treatment of atrial fibrillation.

The Boston Scientific EP Mapping and Navigation System offers industry-defining cardiac mapping, a powerful analysis toolset designed to streamline targeting and clinical decision-making, and unique insights into tissue substrate and lesion formation during RF ablation. Combining intelligence without complexity, the system helps physicians diagnose with greater efficiency and deliver targeted therapy.